Josh Kornberg, MBA

Josh was formerly President, CEO, and Chairman of the Board for a publicly-traded medical device company that focused on the design, manufacture, and market of cost-effective devices that enable minimal healthcare worker exposure to bloodborne pathogens. Previously, Josh also served as Chief Investment Officer of a national private equity firm and Director of a public real estate investment trust. Josh has implemented investment strategies for numerous operating companies and has led the origination and structuring of approximately $10 billion of deal value, including entity level and related financings. Currently, Josh serves as a director of Prospect Park Capital Corp., a publicly-traded private equity fund focused on investments within the healthcare and biotechnology sectors. Josh is also the father of a child with severe food allergies, and is passionate about helping families dealing with food allergies.